Riociguat
Brand name: Adempas
Rank #79 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$236.6M
Total Cost
17,620
Total Claims
$236.6M
Total Cost
407
Prescribers
$13K
Cost per Claim
904
Beneficiaries
17,661
30-Day Fills
$581K
Avg Cost/Provider
43
Avg Claims/Provider
Share of Medicare Part D Spending
0.09%
of total Medicare Part D spending
$236.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $236.6M total
🔎 Data Overview
At $13,427 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $581,289 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $261,708 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Riociguat
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Hunter Champion | Cardiology | Columbus, GA | 975 | $13.2M |
| 2 | Pedro Yapor | Neurology | San Juan, PR | 526 | $6.9M |
| 3 | Ronald Zolty | Advanced Heart Failure and Transplant Cardiology | Omaha, NE | 424 | $5.9M |
| 4 | Eric Roberts | Advanced Heart Failure and Transplant Cardiology | Milwaukee, WI | 385 | $5.2M |
| 5 | Murali Chakinala | Pulmonary Disease | Saint Louis, MO | 353 | $4.9M |
| 6 | Rahul Argula | Pulmonary Disease | Charleston, SC | 311 | $4.3M |
| 7 | Gustavo Heresi Davila | Pulmonary Disease | Cleveland, OH | 309 | $4.1M |
| 8 | Paul Forfia | Advanced Heart Failure and Transplant Cardiology | Philadelphia, PA | 261 | $3.4M |
| 9 | Ricardo Restrepo-Jaramillo | Pulmonary Disease | Tampa, FL | 238 | $3.3M |
| 10 | Vallerie Mclaughlin | Cardiology | Ann Arbor, MI | 236 | $3.1M |
| 11 | George Fahed | Pulmonary Disease | Ponce, PR | 235 | $3.1M |
| 12 | Elba Martin Reyes | Pulmonary Disease | Guaynabo, PR | 232 | $3.0M |
| 13 | Elie Homsy | Pulmonary Disease | Columbus, OH | 211 | $2.8M |
| 14 | Kimberly Thompson | Nurse Practitioner | New Orleans, LA | 192 | $2.6M |
| 15 | Andrew Pogozelski | Advanced Heart Failure and Transplant Cardiology | Pittsburgh, PA | 196 | $2.5M |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 76 | Dolutegravir Sodium (Tivicay) | $251.7M | 102,995 |
| 77 | Abemaciclib (Verzenio) | $242.2M | 16,125 |
| 78 | Abacavir/Dolutegravir/Lamivudi (Triumeq) | $238.1M | 61,147 |
| 79 | Riociguat (Adempas) | $236.6M | 17,620 |
| 80 | Elviteg/Cob/Emtri/Tenof Alafen (Genvoya) | $236.5M | 56,626 |
| 81 | Emtricitabine/Tenofov Alafenam (Descovy) | $222.4M | 94,580 |
| 82 | Immun Glob G(Igg)/Gly/Iga Ov50 (Gammagard Liquid) | $222.1M | 22,768 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology